Stocks In Focus On February 16 After Q3 Results, Orders, Regulatory Updates, And Listings
Last Updated: 16th February 2026 - 10:57 am
Summary:
Stocks such as Ola Electric Mobility, Precision Wires India, Azad Engineering, Fortis Healthcare, Manappuram Finance, Lodha Developers, Deep Industries, Ashoka Buildcon, Aurobindo Pharma, Natco Pharma, Fractal Analytics, Aye Finance, and Jubilant Pharmova will be under focus on February 16 after they announced quarterly results, order wins, regulatory approvals, and listing developments in stock exchanges.
Multiple companies are expected to see investor attention on February 16 after announcing December quarter earnings, fresh order inflows, regulatory clearances, and listing developments, based on disclosures made to the BSE and NSE.
Q3 Earnings Announced
Ola Electric Mobility Ltd reported a narrowing of consolidated net loss to ₹487 crore in Q3FY26, compared with a loss of ₹564 crore in the year-ago quarter. However, revenue declined 55% year-on-year to ₹470 crore from ₹1,045 crore, reflecting continued pressure on volumes during the quarter, according to its exchange filing.
Precision Wires India Ltd posted a 98.9% jump in standalone net profit to ₹37.7 crore in Q3FY26 from ₹18.95 crore a year earlier. Revenue increased 37.2% to ₹1,347.6 crore compared with ₹982.3 crore in the corresponding quarter last year, supported by improved demand and higher sales realisations.
Azad Engineering Ltd reported a 44.3% rise in consolidated net profit to ₹34.5 crore from ₹23.9 crore in Q3FY25. Revenue grew 31.7% to ₹158.7 crore from ₹120.5 crore, driven by strong execution across its aerospace and precision engineering segments.
Fortis Healthcare Ltd recorded a 21.9% decline in consolidated net profit to ₹193.7 crore in Q3FY26, down from ₹247.9 crore in the year-ago period. Revenue rose 17.5% to ₹2,265 crore from ₹1,928.2 crore. The company reported an exceptional loss of ₹45.91 crore during the quarter compared with an exceptional gain of ₹23.8 crore a year earlier, impacting overall profitability.
Lodha Developers Ltd made its December quarter operational performance according to the exchange disclosure, and noted its consistent sales momentum as well as collections in the period. The company also provided updates concerning the launch of projects and continuous developments.
Orders And Corporate Developments
Deep Industries Ltd made exchanges aware that it had a Letter of Award to provide integrated project management services. The order enhances its business operations in the energy services sector and will add to its order book transparency in the next quarters.
Ashoka Buildcon Ltd reported that it has been awarded a new infrastructure project, which further enhanced its order book status. According to the company, the victory in the project is in line with its expansion strategy to increase its presence in major infrastructure segments.
The Reserve Bank of India gave the final approval to Manappuram Finance Ltd on the acquisition of a 41.66% share of BCA India by the entities of BC Asia Investments. According to the firm, the authorisation is a milestone to the proposed transaction, subject to the fulfilment of customary conditions.
Regulatory Updates
In its exchange filing, Aurobindo Pharma Ltd was granted approval by the US Food and Drug Administration for a pharmaceutical product. Marketing of the product in the United States is allowed under approval, and it has diversified its portfolio in the controlled market.
Natco Pharma Ltd notified exchanges regarding concerns about its product portfolio. The company has remained committed to the expansion of its market in major international markets.
Jubilant Pharmova Ltd indicated that its plant located in Montreal received an Official Action Indicated (OAI) rating by the USFDA after the inspection. The company asserted that the remediation measures are in place, and it is striving to have the observations resolved.
Listings And Market Event
The market schedules indicate that Fractal Analytics and Aye Finance will list on the mainboard exchanges on February 16. The listings will appeal to investors as they will be in the primary market.
Official filings and exchange disclosure, these earnings announcements, order wins, regulatory clearances and listing developments are likely to influence the trading activity in the February 16 session.
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
02
5paisa Capital Ltd
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.